Compare FOR & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOR | AHCO |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2007 | 2017 |
| Metric | FOR | AHCO |
|---|---|---|
| Price | $28.36 | $10.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $32.67 | $13.50 |
| AVG Volume (30 Days) | 151.7K | ★ 1.3M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | $1,662,400,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | $0.34 | $9.00 |
| Revenue Next Year | $7.73 | $6.93 |
| P/E Ratio | $17.12 | ★ N/A |
| Revenue Growth | ★ 10.14 | N/A |
| 52 Week Low | $22.81 | $8.51 |
| 52 Week High | $32.06 | $13.43 |
| Indicator | FOR | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 43.58 | 55.80 |
| Support Level | $28.18 | $10.80 |
| Resistance Level | $29.44 | $12.87 |
| Average True Range (ATR) | 1.03 | 0.40 |
| MACD | -0.40 | 0.05 |
| Stochastic Oscillator | 43.38 | 55.61 |
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.